Alvotech - Ordinary Shares — Cash Flow (NASDAQ:ALVO) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -312.39 M-312.19 M-236.84 M-50.2 M — Cash from investing activities -63.54 M-46.34 M-18.87 M-104.22 M — Cash from financing activities 424.91 M301.32 M297.31 M270.83 M — Free cash flow -312.39 M-312.19 M-236.84 M-50.2 M —

News

Alvotech (ALVO) Presents at UBS Virtual Generics and Biosimilars Day Transcript

Alvotech: Speculative 'Buy' Despite The FDA's CMC Requirements (NASDAQ:ALVO)

ALVO Stock Gains 19% on FDA Resubmission of Biosimilar BLAs

Alvotech 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:ALVO) 2026-05-07

Alvotech (ALVO) Reports Q1 Loss, Lags Revenue Estimates

Johnson & Johnson: Why I See Downside Ahead (NYSE:JNJ)

Alvotech: Improving Fundamentals Signal Potential Bottom For This Biosimilar Player (ALVO)

Alvotech 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ALVO) 2026-03-19

Royce Smaller-Companies Growth Fund FY 2025: What Worked… And What Didn’t

Alvotech stock hits 52-week low at 3.65 USD

Alvotech stock hits 52-week low at 3.89 USD

Alvotech stock hits 52-week low at $4.31 amid challenging year